Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michiel de Bruin
Observed names:
M De Bruin,
M de Bruin,
M. De Bruin,
M. de Bruin,
Michiel D. Bruin,
Michiel De Bruin
show all 6
Institution:
OLVG
Observed institutions:
National Institutes of Health,
Erasmus MC,
The Netherlands Cancer Institute,
University Medical Center Utrecht,
OLVG,
Taiho Pharmaceutical (Japan),
National Cancer Institute,
Vrije Universiteit Amsterdam,
Amsterdam UMC Location Vrije Universiteit Amsterdam
show all 9
OpenAlex ID:
A5110109701
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
2008
·
Sven Rottenberg
, Janneke E. Jaspers
, et al.
·
Proceedings of the National Academy of Sciences
·
958
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
2008
·
Bastiaan Evers
, Rinske Drost
, et al.
·
Clinical Cancer Research
·
335
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
1999
·
Michiel de Bruin
, Keisuke Miyake
, et al.
·
Cancer Letters
·
298
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
2010
·
M.A. Vollebergh
, E.H. Lips
, et al.
·
Annals of Oncology
·
200
Therapeutic potential of the dual‐targeted TAS‐102 formulation in the treatment of gastrointestinal malignancies
2007
·
Olaf H. Temmink
, Tomohiro Emura
, et al.
·
Cancer Science
·
108
PDF
Fibroblast Growth Factor Receptor 1–Transformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival
2009
·
Wa Xian
, Leontios Pappas
, et al.
·
Cancer Research
·
74
PDF
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity
2003
·
M de Bruin
, T van Capel
, et al.
·
British Journal of Cancer
·
70
PDF
Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus‐mediated expression of NK4
2004
·
Daniëlle A. M. Heideman
, Victor W. van Beusechem
, et al.
·
The Journal of Gene Medicine
·
40
Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines
2006
·
Olaf H. Temmink
, Michiel de Bruin
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
33
Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells
2005
·
Olaf H. Temmink
, Michiel de Bruin
, et al.
·
Anti-Cancer Drugs
·
29
The Role of Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Tumor Behavior
2008
·
I. V. Bijnsdorp
, M. de Bruin
, et al.
·
Nucleosides Nucleotides & Nucleic Acids
·
28
Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells
2003
·
M de Bruin
, K Smid
, et al.
·
Biochemical and Biophysical Research Communications
·
24
The role of thymidine phosphorylase and uridine phosphorylase in (fluoro)pyrimidine metabolism in peripheral blood mononuclear cells
2006
·
O.H. Temmink
, M. de Bruin
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
20
Sulfasalazine Down-Regulates the Expression of the Angiogenic Factors Platelet-Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase and Interleukin-8 in Human Monocytic-Macrophage THP1 and U937 Cells
2004
·
Michiel de Bruin
, Godefridus J Peters
, et al.
·
Molecular Pharmacology
·
17
Role of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Fluoropyrimidine Sensitivity and Potential Role of Deoxyribose‐1‐Phosphate
2004
·
M. de Bruin
, T. van Capel
, et al.
·
Nucleosides Nucleotides & Nucleic Acids
·
14
Thymidine Phosphorylase in Angiogenesis and Drug Resistance
2002
·
Godefridus J. Peters
, Michiel de Bruin
, et al.
·
Advances in experimental medicine and biology
·
7
Liposomal interference on Sysmex XN-series body fluid mode
2015
·
Chérina Fleming
, Michiel de Bruin
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
5
The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylase
2004
·
Michiel De Bruin
, Toni Van Capel
, et al.
·
European Journal of Pharmacology
·
4
Performance, Safety, and Patient Experience of an Autonomous Robotic Phlebotomy Device: A Multicenter Trial
2026
·
Luuk F P Giesen
, Jeroen A Roest
, et al.
·
Clinical Chemistry
·
2
Role of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Fluoropyrimidine Sensitivity and Potential Role of Deoxyribose‐1‐phosphate
2005
·
M. de Bruin
, T. van Capel
, et al.
·
ChemInform
·
2
Upregulation of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase by Interferon Alpha
2004
·
M. de Bruin
, K. Smid
, et al.
·
Nucleosides Nucleotides & Nucleic Acids
·
2
Falsely decreased ionized calcium results due to analytical interference by teriflunomide, the active metabolite of leflunomide (Arava®)
2012
·
Isabelle Hubeek
, Alferso C. Abrahams
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
1
Thymidine phosphorylase in angiogenesis and drug resistance. Homology with platelet-derived endothelial cell growth factor.
2000
·
G J Peters
, M De Bruin
, et al.
·
PubMed
·
1
Establishment and characterization of porcine cytolytic cell lines and clones
1997
·
M. de Bruin
, J. Voermans
, et al.
·
Immunology Letters
·
1
Data from Fibroblast Growth Factor Receptor 1–Transformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival
2023
·
Wa Xian
, Leontios Pappas
, et al.
Show more works
View as search
Works count:
41
Citation count:
2,273
H-index:
14
I10-index:
15
Year
Topic
Type
